Unequal Behaviour between Hydrolysable Functions of Nirmatrelvir under Stress Conditions: Structural and Theoretical Approaches in Support of Preformulation Studies

• Κύριοι συγγραφείς: Philippe-Henri Secretan (Συγγραφέας), Maxime Annereau (Συγγραφέας), Willy Kini-Matondo (Συγγραφέας), Bastien Prost (Συγγραφέας), Jade Prudhomme (Συγγραφέας), Lina Bournane (Συγγραφέας), Muriel Paul (Συγγραφέας), Najet Yagoubi (Συγγραφέας), Hassane Sadou-Yayé (Συγγραφέας), Bernard Do (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Nirmatrelvir is an antiviral drug approved for the treatment of COVID-19. The available dosage form consists of tablets marketed under the brand name PAXLOVID^®. Although knowledge of nirmatrelvir's intrinsic stability may be useful for any potential development of other p...